Item no. |
ELS-PKSH032444-50ug |
Manufacturer |
Elabscience
|
Amount |
50 ug |
Quantity options |
10 ug
50 ug
|
Category |
|
Type |
Proteins |
Format |
Lyophilized Powder |
Applications |
ELISA |
Specific against |
Human (Homo sapiens) |
Host |
E.coli |
Conjugate/Tag |
Untagged |
Purity |
> 95 % as determined by reducing SDS-PAGE. |
Sequence |
Cys32-Thr194 |
ECLASS 10.1 |
32160409 |
ECLASS 11.0 |
32160409 |
UNSPSC |
12352202 |
Alias |
FGF-7, FGF7, Fibroblast growth factor 7, HBGF-7, Heparin-binding growth factor 7, KGF, Keratinocyte growth factor |
Similar products |
FGF7, KGF, HBGF-7, FGF-7, Fibroblast growth factor 7, Keratinocyte growth factor, Heparin-binding growth factor 7 |
Shipping condition |
Cool pack |
Available |
|
Manufacturer - Category |
Recombinant Proteins / Cytokines |
Manufacturer - Conjugate / Tag |
None |
Shipping Temperature |
This product is provided as lyophilized powder which is shipped with ice packs. |
Storage Conditions |
Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months. |
Calculated Molecular Weight |
18.9 kDa |
Observed Molecular Weight |
17 kDa |
Research Areas |
Signal Transduction, Cancer, |
Background |
Fibroblast growth factor 7 (FGF7) is a secreted protein which is mainly located in epithelial cells and belongs to the heparin-binding growth factors family. FGF family members possess broad mitogenic and cell survival activities; and are involved in a variety of biological processes; including embryonic development; cell growth; morphogenesis; tissue repair; tumor growth and invasion. FGF7 is a potent epithelial cell-specific growth factor; whose mitogenic activity is predominantly exhibited in keratinocytes but not in fibroblasts and endothelial cells. It is possible major paracrine effector of normal epithelial cell proliferation. |
Abbreviation |
FGF-7; KGF |
Endotoxin |
< 1.0 EU per μg of the protein as determined by the LAL method. |
Reconstitution |
Please refer to the printed manual for detailed information. |
Formulation |
Lyophilized from a 0.2 μm filtered solution of 20mM Tris,1mM EDTA,5% Trehalose, 0.02% Tween 80, pH 8.0. Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual. |
Activity |
Not validated for activity |
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.